Donate

info@cureduchenne.org(949) 872-2552

Events Contact

Cart

×

No products in the cart.

Cure
Care
Community
About Us
CD Ventures
Get Involved
Donate

Capricor Announces Receipt of FDA Clearance for the Phase I/II Study of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy Related Cardiomyopathy

June 8, 2015 - Posted in Research Articles

Related Posts

CureDuchenne Ventures Commits $500,000 to 4D Molecular Therapeutics to Advance Next-Generation AAV Delivery of Gene Therapy

September 7, 2018
Crispr Halted Muscular Dystrophy In Dogs. Someday, It Might Cure Humans.

August 30, 2018
Significant Improvements Reported in Duchenne Muscular Dystrophy Patients Treated with Capricor’s Investigational Cell Therapy

November 15, 2017
Exonics Therapeutics Raises $40 Million in Series A Financing

November 8, 2017

Share This Page

Make an Impact

You can advance the care, treatment and cure for Duchenne muscular dystrophy. Contributions in any amount can truly make a difference and can be credited to a fundraiser or event from the list below.

Donate

Search

Search for:

Recent Posts

Handling Emergencies
May 7, 2024
Global Nonprofit CureDuchenne to Host FUTURES National Conference for the Duchenne and Becker Muscular Dystrophy Community on May 23-26 in Orlando, FL
May 7, 2024
Rolling Through the Magic: Exploring Disneyland in a Power Wheelchair
May 3, 2024
Napa in Newport Celebrates a Decade of Impact and Raises More Than $1.35M for CureDuchenne
April 24, 2024
How You Can Drive with a Disability
April 19, 2024

Categories

Cure Duchenne Blog
Press Releases
In the News
Research Articles

Categories

All Categories
2023 FUTURES
Clinical Care
Community
Equipment
Financial Assistance
Industry Presentations
Mental Health
Physical Therapy
Recursos en español
Research and Clinical Trials
School

About
- Mission
- About Duchenne MD
- Blog
- Store
- News Center
Get Involved
CureDuchenne
- 100 Bayview Circle, Suite 5600
  Newport Beach, CA 92660
  (949) 872-2552
  info@cureduchenne.org
Get Connected

PRIVACY POLICY | TERMS OF USE | INDIRECT COST POLICY | TAX INFO

CureDuchenne is a 501c3 registered tax-exempt nonprofit organization. Federal Tax ID: #20-0299958 | ©2024 CureDuchenne. All rights reserved.

Please be advised that the contents within the CureDuchenne site include a compilation of articles, advisements, and references from the community. CureDuchenne does not provide medical advice nor is CureDuchenne a medical provider. The intent of this shared content is to serve as a point of reference for informational purposes. Please refer to your health care provider(s) for your individualized, specific care management needs. The CureDuchenne website may contain links to external websites that are not provided and/or maintained by or in any way affiliated with CureDuchenne. CureDuchenne recommends that you review the terms of service and privacy policies of these external websites before entering. Please note that CureDuchenne does not guarantee the accuracy, relevance, timeliness, or completeness of any information on these external websites.

We use cookies to ensure that we give you the best experience on our website. By continuing to use this site you are agreeing to accept our use of cookies. For more information about cookies please visit our Privacy Policy page.I Agree